{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:25:43Z","timestamp":1776284743069,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Eng"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Efflux pump activity has been associated with multidrug resistance phenotypes in bacteria, compromising the effectiveness of antimicrobial therapy. The development of methods for the early detection and quantification of drug transport across the bacterial cell wall is a tool essential to understand and overcome this type of drug resistance mechanism. This approach was developed to study the transport of the efflux pump substrate ethidium bromide (EtBr) across the cell envelope of <jats:italic>Escherichia coli<\/jats:italic> K-12 and derivatives, differing in the expression of their efflux systems.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>EtBr transport across the cell envelope of <jats:italic>E. coli<\/jats:italic> K-12 and derivatives was analysed by a semi-automated fluorometric method. Accumulation and efflux of EtBr was studied under limiting energy supply (absence of glucose and low temperature) and in the presence and absence of the efflux pump inhibitor, chlorpromazine. The bulk fluorescence variations were also observed by single-cell flow cytometry analysis, revealing that once inside the cells, leakage of EtBr does not occur and that efflux is mediated by active transport. The importance of AcrAB-TolC, the main efflux system of <jats:italic>E. coli<\/jats:italic>, in the extrusion of EtBr was evidenced by comparing strains with different levels of AcrAB expression. An experimental model was developed to describe the transport kinetics in the three strains. The model integrates passive entry (influx) and active efflux of EtBr, and discriminates different degrees of efflux between the studied strains that vary in the activity of their efflux systems, as evident from the calculated efflux rates: \"Equation missing\" = 0.0173 \u00b1 0.0057 min<jats:sup>-1<\/jats:sup>; \"Equation missing\" = 0.0106 \u00b1 0.0033 min<jats:sup>-1<\/jats:sup>; and \"Equation missing\" = 0.0230 \u00b1 0.0075 min<jats:sup>-1<\/jats:sup>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The combined use of a semi-automated fluorometric method and an experimental model allowed quantifying EtBr transport in <jats:italic>E. coli<\/jats:italic> strains that differ in their overall efflux activity. This methodology can be used for the early detection of differences in the drug efflux capacity in bacteria accounting for antibiotic resistance, as well as for expedite screening of new drug efflux inhibitors libraries and transport studies across the bacterial cell wall.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1754-1611-3-18","type":"journal-article","created":{"date-parts":[[2009,10,16]],"date-time":"2009-10-16T18:18:17Z","timestamp":1255717097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":171,"title":["Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli"],"prefix":"10.1186","volume":"3","author":[{"given":"Laura","family":"Paix\u00e3o","sequence":"first","affiliation":[]},{"given":"Liliana","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Couto","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Carla CCR","family":"de Carvalho","sequence":"additional","affiliation":[]},{"given":"Gabriel A","family":"Monteiro","sequence":"additional","affiliation":[]},{"given":"Filipe","family":"Sansonetty","sequence":"additional","affiliation":[]},{"given":"Leonard","family":"Amaral","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Viveiros","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,10,16]]},"reference":[{"key":"44_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2165\/00003495-200464020-00004","volume":"64","author":"XZ Li","year":"2004","unstructured":"Li XZ, Nikaido H: Efflux-mediated drug resistance in bacteria. Drugs 2004, 64: 159-204. 10.2165\/00003495-200464020-00004","journal-title":"Drugs"},{"key":"44_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro1464","volume":"4","author":"LJ Piddock","year":"2006","unstructured":"Piddock LJ: Multidrug-resistance efflux pumps - not just for resistance. Nat Rev Microbiol 2006, 4: 629-636. 10.1038\/nrmicro1464","journal-title":"Nat Rev Microbiol"},{"key":"44_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/276090a0","volume":"276","author":"SB Levy","year":"1978","unstructured":"Levy SB, McMurry L: Plasmid-determined tetracycline resistance involves new transport systems for tetracycline. Nature 1978, 276: 90-92. 10.1038\/276090a0","journal-title":"Nature"},{"key":"44_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/157489106777452692","volume":"1","author":"FV Bambeke","year":"2006","unstructured":"Bambeke FV, Pag\u00e8s JM, Lee VJ: Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux. Recent Patents Anti-Infect Drug Disc 2006, 1: 157-175. 10.2174\/157489106777452692","journal-title":"Recent Patents Anti-Infect Drug Disc"},{"key":"44_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.molmed.2005.06.006","volume":"11","author":"JM Pag\u00e8s","year":"2005","unstructured":"Pag\u00e8s JM, Masi M, Barbe J: Inhibitors of efflux pumps in Gram-negative bacteria. Trends Mol Med 2005, 11: 382-389. 10.1016\/j.molmed.2005.06.006","journal-title":"Trends Mol Med"},{"key":"44_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrd2200","volume":"6","author":"O Lomovskaya","year":"2007","unstructured":"Lomovskaya O, Zgurskaya HI, Totrov M, Watkins WJ: Waltzing transporters and 'the dance macabre' between humans and bacteria. Nat Rev Drug Discov 2007, 6: 56-65. 10.1038\/nrd2200","journal-title":"Nat Rev Drug Discov"},{"key":"44_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/07853890701195262","volume":"39","author":"K Poole","year":"2007","unstructured":"Poole K: Efflux pumps as antimicrobial resistance mechanisms. Ann Med 2007, 39: 162-176. 10.1080\/07853890701195262","journal-title":"Ann Med"},{"key":"44_CR8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/CMR.19.2.382-402.2006","volume":"19","author":"LJ Piddock","year":"2006","unstructured":"Piddock LJ: Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 2006, 19: 382-402. 10.1128\/CMR.19.2.382-402.2006","journal-title":"Clin Microbiol Rev"},{"key":"44_CR9","first-page":"55","volume-title":"Antimicrobial resistance in bacteria","author":"A Davin-Regli","year":"2007","unstructured":"Davin-Regli A, Pag\u00e8s JM: Regulation of efflux pumps in Enterobacteriaceae: genetic and chemical effectors. In Antimicrobial resistance in bacteria. Edited by: Amabile-Cuevas CF. Norfolk, UK: Horizon Bioscience; 2007:55-75."},{"key":"44_CR10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/jb.178.1.306-308.1996","volume":"178","author":"H Okuso","year":"1996","unstructured":"Okuso H, Ma D, Nikaido H: AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol 1996, 178: 306-308.","journal-title":"J Bacteriol"},{"issue":"4","key":"44_CR11","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1371\/journal.pone.0000365","volume":"2","author":"M Viveiros","year":"2007","unstructured":"Viveiros M, Dupont M, Rodrigues L, Couto I, Davin-Regli A, Pag\u00e8s JM, Amaral L: Antibiotic Stress, Genetic Response and Altered Permeability of E. coli . PLoS ONE 2007,2(4):e365. 10.1371\/journal.pone.0000365","journal-title":"PLoS ONE"},{"key":"44_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2174\/138945008785747743","volume":"9","author":"ZV Pietras","year":"2008","unstructured":"Pietras ZV, Bavro N, Furnham N, Pellegrini-Calace M, Milner-White EJ, Luisi BF: Structure and mechanism of drug efflux machinery in Gram negative bacteria. Curr Drug Targets 2008, 9: 719-728. 10.2174\/138945008785747743","journal-title":"Curr Drug Targets"},{"key":"44_CR13","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1128\/AAC.49.8.3578-3582.2005","volume":"49","author":"M Viveiros","year":"2005","unstructured":"Viveiros M, Jesus A, Brito M, Leandro C, Martins M, Ordway D, Molnar M, Molnar J, Amaral L: Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of proton gradient-dependent multidrug efflux pump genes. Antimicrob Agents Chemother 2005, 49: 3578-3582. 10.1128\/AAC.49.8.3578-3582.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"44_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2174\/138945008785747824","volume":"9","author":"A Davin-Regli","year":"2008","unstructured":"Davin-Regli A, Bolla JM, James CE, Lavigne JP, Chevalier J, Garnotel E, Molitor A, Pag\u00e8s JM: Membrane permeability and regulation of drug \"influx and efflux\" in enterobacterial pathogens. Curr Drug Targets 2008, 9: 750-759. 10.2174\/138945008785747824","journal-title":"Curr Drug Targets"},{"key":"44_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/1389201043376878","volume":"5","author":"KO Greulich","year":"2004","unstructured":"Greulich KO: Single molecule techniques for biomedicine and pharmacology. Curr Pharm Biotechnol 2004, 5: 243-259. 10.2174\/1389201043376878","journal-title":"Curr Pharm Biotechnol"},{"key":"44_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/cyto.990170405","volume":"17","author":"MW Jernaes","year":"1994","unstructured":"Jernaes MW, Steen HB: Staining of Escherichia coli for flow cytometry: influx and efflux of ethidium bromide. Cytometry 1994, 17: 302-309. 10.1002\/cyto.990170405","journal-title":"Cytometry"},{"key":"44_CR17","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S1286-4579(00)01307-1","volume":"2","author":"F Joux","year":"2000","unstructured":"Joux F, Lebaron P: Use of fluorescent probes to assess physiological functions of bacteria at single-cell level. Microbes Infect 2000, 2: 1523-1535. 10.1016\/S1286-4579(00)01307-1","journal-title":"Microbes Infect"},{"key":"44_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1021\/bi0351110","volume":"43","author":"SV Kyriacou","year":"2004","unstructured":"Kyriacou SV, Brownlow WJ, Xu XHN: Using nanopartical optics assay for direct observation of the function of antimicrobial agents in single live bacterial cells. Biochemistry 2004, 43: 140-147. 10.1021\/bi0351110","journal-title":"Biochemistry"},{"key":"44_CR19","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.bcp.2005.12.008","volume":"71","author":"O Lomovskaya","year":"2006","unstructured":"Lomovskaya O, Bostian KA: Practical applications and feasibility of efflux pump inhibitors in the clinic - a vision for applied use. Biochem Pharmacol 2006, 71: 910-918. 10.1016\/j.bcp.2005.12.008","journal-title":"Biochem Pharmacol"},{"key":"44_CR20","first-page":"657","volume":"20","author":"M Martins","year":"2006","unstructured":"Martins M, Santos B, Martins A, Viveiros M, Couto I, Cruz A, Pag\u00e8s JM, Molnar J, Fanning S, Amaral L, Management Committee Members of Cost B16 European Commission\/European Science Foundation: An instrument-free method for the demonstration of efflux pump activity of bacteria. In vivo 2006, 20: 657-664.","journal-title":"In vivo"},{"key":"44_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/jac\/28.5.639","volume":"28","author":"PG Mortimer","year":"1991","unstructured":"Mortimer PG, Piddock LJ: A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus . J Antimicrob Chemother 1991, 28: 639-653. 10.1093\/jac\/28.5.639","journal-title":"J Antimicrob Chemother"},{"key":"44_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ijantimicag.2007.12.015","volume":"31","author":"M Viveiros","year":"2008","unstructured":"Viveiros M, Martins A, Paix\u00e3o L, Rodrigues L, Martins M, Couto I, F\u00e4hnrich E, Kern WV, Amaral L: Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. Int J Antimicrob Agents 2008, 31: 458-462. 10.1016\/j.ijantimicag.2007.12.015","journal-title":"Int J Antimicrob Agents"},{"key":"44_CR23","doi-asserted-by":"publisher","first-page":"760","DOI":"10.2174\/138945008785747734","volume":"9","author":"M Viveiros","year":"2008","unstructured":"Viveiros M, Martins M, Couto I, Rodrigues L, Spengler G, Martins A, Kristiansen JE, Molnar J, Amaral L: New methods for the identification of efflux mediated MDR bacteria, genetic assessment of regulators and efflux pump constituents, characterization of efflux systems and screening for inhibitors of efflux pumps. Curr Drug Targets 2008, 9: 760-778. 10.2174\/138945008785747734","journal-title":"Curr Drug Targets"},{"key":"44_CR24","volume-title":"Rotor-Gene 3000 Real-Time Amplification. Operator's Manual Version 4.6","author":"Corbett Research","year":"2003","unstructured":"Corbett Research: Rotor-Gene 3000 Real-Time Amplification. Operator's Manual Version 4.6. Corbett Research, Sydney, Australia; 2003."},{"key":"44_CR25","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15","author":"Clinical and Laboratory Standards Institute","year":"2005","unstructured":"Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA; 2005."},{"key":"44_CR26","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1128\/JB.182.11.3142-3150.2000","volume":"182","author":"A Lee","year":"2000","unstructured":"Lee A, Mao W, Warren MS, Mistry A, Hoshino K, Okumura R, Ishida H, Lomovskaya O: Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J Bacteriol 2000, 182: 3142-3150. 10.1128\/JB.182.11.3142-3150.2000","journal-title":"J Bacteriol"},{"key":"44_CR27","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2174\/138945008785747789","volume":"9","author":"MA Seeger","year":"2008","unstructured":"Seeger MA, Diederichs K, Eicher T, Brandst\u00e4tter L, Schiefner A, Verrey F, Pos KM: The AcrB efflux pump: conformational cycling and peristalsis lead to multidrug resistance. Curr Drug Targets 2008, 9: 729-749. 10.2174\/138945008785747789","journal-title":"Curr Drug Targets"},{"key":"44_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijantimicag.2007.10.025","volume":"31","author":"M Martins","year":"2008","unstructured":"Martins M, Dastidar SG, Fanning S, Kristiansen JE, Molnar J, Pag\u00e8s JM, Schelz Z, Spengler G, Viveiros M, Amaral L: Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities. Int J Antimicrob Agents 2008, 31: 198-208. 10.1016\/j.ijantimicag.2007.10.025","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Biological Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1754-1611-3-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T09:15:33Z","timestamp":1630487733000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbioleng.biomedcentral.com\/articles\/10.1186\/1754-1611-3-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,16]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["44"],"URL":"https:\/\/doi.org\/10.1186\/1754-1611-3-18","relation":{},"ISSN":["1754-1611"],"issn-type":[{"value":"1754-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,16]]},"assertion":[{"value":"29 July 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"18"}}